======= TBX3 ======= == Gene Information == * **Official Symbol**: TBX3 * **Official Name**: T-box transcription factor 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6926|6926]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15119|O15119]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBX3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBX3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601621|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This protein is a transcriptional repressor and is thought to play a role in the anterior/posterior axis of the tetrapod forelimb. Mutations in this gene cause ulnar-mammary syndrome, affecting limb, apocrine gland, tooth, hair, and genital development. Alternative splicing of this gene results in three transcript variants encoding different isoforms; however, the full length nature of one variant has not been determined. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Transcriptional repressor involved in developmental processes. Probably plays a role in limb pattern formation. Acts as a negative regulator of PML function in cellular senescence. {ECO:0000269|PubMed:10468588, ECO:0000269|PubMed:22002537}. |T-box| |TBX| |follicle-stimulating hormone secretion| |atrioventricular bundle cell differentiation| |sinoatrial node cell development| |His-Purkinje system cell differentiation| |sinoatrial node cell differentiation| |sinoatrial node development| |luteinizing hormone secretion| |mammary placode formation| |specification of animal organ position| |cardiac pacemaker cell development| |bundle of His development| |gonadotropin secretion| |His-Purkinje system development| |cardiac pacemaker cell differentiation| |cardiac muscle cell fate commitment| |mammary gland formation| |cardiac cell fate commitment| |endocrine hormone secretion| |ectodermal placode morphogenesis| |ectodermal placode formation| |cardiac conduction system development| |ectodermal placode development| |anterior/posterior axis specification, embryo| |muscle cell fate commitment| |tripartite regional subdivision| |female genitalia development| |blastoderm segmentation| |branching involved in mammary gland duct morphogenesis| |male genitalia development| |negative regulation of myoblast differentiation| |embryonic hindlimb morphogenesis| |mammary gland duct morphogenesis| |cellular senescence| |embryonic forelimb morphogenesis| |hindlimb morphogenesis| |embryonic axis specification| |positive regulation of stem cell proliferation| |negative regulation of epithelial cell differentiation| |forelimb morphogenesis| |ventricular septum morphogenesis| |mammary gland morphogenesis| |genitalia development| |endocrine process| |anterior/posterior axis specification| |RNA polymerase II activating transcription factor binding| |regulation of myoblast differentiation| |ventricular cardiac muscle tissue development| |mammary gland epithelium development| |heart looping| |cardiac muscle cell development| |embryonic digit morphogenesis| |RNA polymerase II transcription factor binding| |embryonic pattern specification| |cell aging| |regulation of stem cell proliferation| |cardiac cell development| |determination of heart left/right asymmetry| |embryonic heart tube morphogenesis| |mesoderm morphogenesis| |ventricular septum development| |hormone secretion| |outflow tract morphogenesis| |cardiac septum morphogenesis| |embryonic heart tube development| |hormone transport| |axis specification| |cardiac muscle cell differentiation| |cell fate specification| |roof of mouth development| |segmentation| |gland morphogenesis| |female sex differentiation| |limbic system development| |cardiac septum development| |cardiocyte differentiation| |determination of left/right symmetry| |determination of bilateral symmetry| |specification of symmetry| |mesoderm development| |embryonic appendage morphogenesis| |embryonic limb morphogenesis| |cardiac chamber morphogenesis| |mammary gland development| |cardiac ventricle development| |branching morphogenesis of an epithelial tube| |stem cell population maintenance| |striated muscle cell development| |maintenance of cell number| |regulation of epithelial cell differentiation| |muscle cell development| |limb morphogenesis| |appendage morphogenesis| |male sex differentiation| |morphogenesis of a branching epithelium| |cardiac muscle tissue development| |morphogenesis of a branching structure| |signal release| |cardiac chamber development| |limb development| |appendage development| |striated muscle cell differentiation| |anterior/posterior pattern specification| |muscle cell differentiation| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |cell fate commitment| |heart morphogenesis| |sex differentiation| |aging| |striated muscle tissue development| |embryonic organ morphogenesis| |muscle tissue development| |epithelial tube morphogenesis| |RNA polymerase II regulatory region sequence-specific DNA binding| |regionalization| |in utero embryonic development| |positive regulation of cell cycle| |forebrain development| |gland development| |sequence-specific DNA binding| |reproductive structure development| |reproductive system development| |morphogenesis of an epithelium| |embryonic organ development| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |muscle structure development| |blood vessel development| |skeletal system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |heart development| |regulation of hormone levels| |tissue morphogenesis| |embryonic morphogenesis| |chordate embryonic development| |embryo development ending in birth or egg hatching| |tube morphogenesis| |developmental process involved in reproduction| |negative regulation of cell differentiation| |brain development| |head development| |tube development| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |negative regulation of programmed cell death| |positive regulation of cell population proliferation| |negative regulation of developmental process| |animal organ morphogenesis| |embryo development| |central nervous system development| |negative regulation of cell death| |secretion by cell| |export from cell| |epithelium development| |cell-cell signaling| |secretion| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |regulation of cell death| |cellular response to stress| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-2.02| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|-1.9| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 4/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|2/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|1/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11077 * **Expression level (log2 read counts)**: -2.01 {{:chemogenomics:nalm6 dist.png?nolink |}}